%0 Journal Article
%T Management of Testicular Cancers in Brazzaville
%A Roland Bertile Banga-Mouss
%A Yanick Dimi Nyanga
%A Brice Nkoua Epala
%A Armel Melvin Atipo Ondongo
%A Steve Aristid Ondziel-Opara
%A Eliane Ndounga
%A Alexis Bolenga
%A Louis Constant Mbele Mantsouaka
%A Judith Nsonde Malanda
%A Aanani S&#233
%A verin Wencesl Odz&#233
%A b&#233
%A Prosper Alain Bouya
%J Open Journal of Urology
%P 324-332
%@ 2160-5629
%D 2024
%I Scientific Research Publishing
%R 10.4236/oju.2024.145034
%X <b>Introduction:</b> Testicular cancer accounts for 5% of urological tumors, predominantly affecting young men. The aim of our study was to report the diagnostic and evolutionary aspects of testicular cancer cases treated in our center. <b>Patients and Methods:</b> A retrospective study conducted over a 15-year period involving 12 patients treated for testicular cancer at the University Hospital of Brazzaville. <b>Results:</b> The median age was 31 years (range 11 to 49 years), with a median consultation delay of 10.6 months (range 3 to 27 months). Scrotal mass was the most common reason for consultation. Cancer was bilateral in two patients. Two patients were admitted with metastatic disease. Histopathological examination favored germ cell tumors in 7 cases, two cases of non-Hodgkin’s malignant lymphoma, and one case of epididymo-testicular adenocarcinoma. Adjuvant chemotherapy resulted in complete remission in patients with germ cell tumors. However, neoadjuvant chemotherapy was not effective in patients admitted with advanced-stage disease. <b>Conclusion:</b> Testicular cancer is a rare condition that is curable in the majority of cases, but its management is often complicated in our setting due to delayed diagnosis caused by taboos surrounding genital organ pathologies.
%K Testicular Cancer
%K Germ Cell Tumor
%K Cisplatin
%K Testicular Lymphoma
%K Testicular Adenocarcinoma
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=133224